Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia 22Lymphoma 14Leukemia, Myeloid, Acute 14Myelodysplastic Syndromes 12Leukemia, Lymphocytic, Chronic, B-Cell 12Breast Neoplasms 11Prostatic Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Multiple Myeloma 9Melanoma 9Lymphoma, Follicular 9Neuroblastoma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Ovarian Neoplasms 7Congenital Abnormalities 7Lymphoma, Non-Hodgkin 6Hodgkin Disease 5Neoplasms, Plasma Cell 4Neoplasm Metastasis 4Myeloproliferative Disorders 4Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Chronic-Phase 4Glioblastoma 4Fallopian Tube Neoplasms 4Anemia, Refractory, with Excess of Blasts 4Waldenstrom Macroglobulinemia 3Osteosarcoma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3

Interventions

Cyclophosphamide 13Etoposide 10Prednisone 8Doxorubicin 8Whole-Body Irradiation 7Vincristine 7Rituximab 7Peripheral Blood Stem Cell Transplantation 7Melphalan 7Brentuximab Vedotin 7romidepsin 6fludarabine phosphate 6Mycophenolic Acid 6fludarabine 5Lenalidomide 5Gemcitabine 5Cytarabine 510-propargyl-10-deazaaminopterin 5Tacrolimus 4Granulocyte Colony-Stimulating Factor 4Carmustine 4Busulfan 4Antilymphocyte Serum 4pembrolizumab 3etoposide phosphate 3carmustine, poliferprosan 20 drug combination 3Vorinostat 3Sirolimus 3Nivolumab 3Filgrastim 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, T-Cell × sargramostim × Clear all
NCT00505921 2011-11-16

Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma

M.D. Anderson Cancer Center

Phase 2 Terminated
27 enrolled 5 charts
Lymphoid

Lymphoma, Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡